Cargando…
ATP protects anti-PD-1/radiation-induced cardiac dysfunction by inhibiting anti-PD-1 exacerbated cardiomyocyte apoptosis, and improving autophagic flux
The synergy between radiotherapy and immunotherapy in treating thoracic cancers presents a potent therapeutic advantage, yet it also carries potential risks. The extent and nature of cumulative cardiac toxicity remain uncertain, prompting the need to discern its mechanisms and devise effective mitig...
Autores principales: | Wang, Jing, Zhao, Jing, Meng, Zhijun, Guo, Rui, Yang, Ruihong, Liu, Caihong, Gao, Jia, Xie, Yaoli, Jiao, Xiangying, Fang, Heping, Zhao, Jianli, Wang, Yajing, Cao, Jimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570000/ https://www.ncbi.nlm.nih.gov/pubmed/37842574 http://dx.doi.org/10.1016/j.heliyon.2023.e20660 |
Ejemplares similares
-
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
por: Chen, Jiming, et al.
Publicado: (2022) -
Nicotine aggravates vascular adiponectin resistance via ubiquitin-mediated adiponectin receptor degradation in diabetic Apolipoprotein E knockout mouse
por: Gao, Jia, et al.
Publicado: (2021) -
PXDN reduces autophagic flux in insulin-resistant cardiomyocytes via modulating FoxO1
por: Li, Chan, et al.
Publicado: (2021) -
The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
por: Tunger, Antje, et al.
Publicado: (2019) -
The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
por: Sui, Xinbing, et al.
Publicado: (2015)